# N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)

> **NCT00374088** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 21 (actual)

## Conditions studied

- Transposition of Great Vessels
- Congenital Heart Disease

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00374088
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374088, "N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00374088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*